Please provide your email address to receive an email when new articles are posted on . Patients used between 5 mg and 40 mg of oral corticosteroids each day for 3 months before the study. 82.2% of ...
Please provide your email address to receive an email when new articles are posted on . Patients had mild asthma and uncontrolled symptoms. Doses included an albuterol-budesonide combination or ...
Tezspire (tezepelumab-ekko) is a monthly injection used to treat severe asthma. It was approved by the FDA in 2021 for use in addition to other asthma controlling medicines in people 12 and older.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results